Literature DB >> 18805044

Dysregulated molecular networks in head and neck carcinogenesis.

Alfredo A Molinolo1, Panomwat Amornphimoltham, Cristiane H Squarize, Rogerio M Castilho, Vyomesh Patel, J Silvio Gutkind.   

Abstract

Multiple genetic and epigenetic events, including the aberrant expression and function of molecules regulating cell signaling, growth, survival, motility, angiogenesis, and cell cycle control, underlie the progressive acquisition of a malignant phenotype in squamous carcinomas of the head and neck (HNSCC). In this regard, there has been a recent explosion in our understanding on how extracellular components, cell surface molecules, and a myriad of intracellular proteins and second messenger systems interact with each other, and are organized in pathways and networks to control cellular and tissue functions and cell fate decisions. This emerging ability to understand the basic mechanism controlling inter- and intra-cellular communication has provided an unprecedented opportunity to understand how their dysregulation contributes to the growth and dissemination of human cancers. Here, we will discuss the emerging information on how the use of modern technologies, including gene array and proteomic studies, combined with the molecular dissection of aberrant signaling networks, including the EGFR, ras, NFkappaB, Stat, Wnt/beta-catenin, TGF-beta, and PI3K-AKT-mTOR signaling pathways, can help elucidate the molecular mechanisms underlying HNSCC progression. Ultimately, we can envision that this knowledge may provide tremendous opportunities for the diagnosis of premalignant squamous lesions, and for the development of novel molecular-targeted strategies for the prevention and treatment of HNSCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805044      PMCID: PMC2743485          DOI: 10.1016/j.oraloncology.2008.07.011

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  147 in total

Review 1.  Tracking STAT nuclear traffic.

Authors:  Nancy C Reich; Ling Liu
Journal:  Nat Rev Immunol       Date:  2006-08       Impact factor: 53.106

2.  Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma.

Authors:  Carmen J Marsit; Michael D McClean; Constance Sloane Furniss; Karl T Kelsey
Journal:  Int J Cancer       Date:  2006-10-15       Impact factor: 7.396

Review 3.  Shared principles in NF-kappaB signaling.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

4.  Expression of Stat5A in tobacco chewing-mediated oral squamous cell carcinoma.

Authors:  Priyanka Kar; Prakash C Supakar
Journal:  Cancer Lett       Date:  2005-11-21       Impact factor: 8.679

5.  Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.

Authors:  John C Sok; Francesca M Coppelli; Sufi M Thomas; Miriam N Lango; Sichuan Xi; Jennifer L Hunt; Maria L Freilino; Michael W Graner; Carol J Wikstrand; Darell D Bigner; William E Gooding; Frank B Furnari; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2006-09-01       Impact factor: 12.531

6.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; William F Anderson; Maura L Gillison
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

7.  TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

Authors:  M Luana Poeta; Judith Manola; Meredith A Goldwasser; Arlene Forastiere; Nicole Benoit; Joseph A Califano; John A Ridge; Jarrard Goodwin; Daniel Kenady; John Saunders; William Westra; David Sidransky; Wayne M Koch
Journal:  N Engl J Med       Date:  2007-12-20       Impact factor: 91.245

8.  Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.

Authors:  Avaniyapuram Kannan Murugan; Nguyen Thi Hong; Yasuhisa Fukui; Arasambattu Kannan Munirajan; Nobuo Tsuchida
Journal:  Int J Oncol       Date:  2008-01       Impact factor: 5.650

Review 9.  Recent advances in Oral Oncology 2007: epidemiology, aetiopathogenesis, diagnosis and prognostication.

Authors:  Jose V Bagan; Crispian Scully
Journal:  Oral Oncol       Date:  2008-02       Impact factor: 5.337

Review 10.  Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma.

Authors:  D E Costea; O Tsinkalovsky; O K Vintermyr; A C Johannessen; I C Mackenzie
Journal:  Oral Dis       Date:  2006-09       Impact factor: 3.511

View more
  148 in total

1.  mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas.

Authors:  Alfredo A Molinolo; Christina Marsh; Mohamed El Dinali; Nitin Gangane; Kaitlin Jennison; Stephen Hewitt; Vyomesh Patel; Tanguy Y Seiwert; J Silvio Gutkind
Journal:  Clin Cancer Res       Date:  2012-03-12       Impact factor: 12.531

Review 2.  NF-κB addiction and its role in cancer: 'one size does not fit all'.

Authors:  M M Chaturvedi; B Sung; V R Yadav; R Kannappan; B B Aggarwal
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

3.  Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples.

Authors:  Mitchell J Frederick; Amy J VanMeter; Mayur A Gadhikar; Ying C Henderson; Hui Yao; Curtis C Pickering; Michelle D Williams; Adel K El-Naggar; Vlad Sandulache; Emily Tarco; Jeffrey N Myers; Gary L Clayman; Lance A Liotta; Emanuel F Petricoin; Valerie S Calvert; Valentina Fodale; Jing Wang; Randal S Weber
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Microgenomics of ameloblastoma.

Authors:  P DeVilliers; C Suggs; D Simmons; V Murrah; J T Wright
Journal:  J Dent Res       Date:  2011-01-31       Impact factor: 6.116

5.  Treatment effect of buparlisib, cetuximab and irradiation in wild-type or PI3KCA-mutated head and neck cancer cell lines.

Authors:  Laura Lattanzio; Federica Tonissi; Martino Monteverde; Daniela Vivenza; Elvio Russi; Gérard Milano; Marco Merlano; Cristiana Lo Nigro
Journal:  Invest New Drugs       Date:  2015-01-22       Impact factor: 3.850

6.  Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.

Authors:  Cornelia Johanna Franziska Scheitz; Tae Seung Lee; David James McDermitt; Tudorita Tumbar
Journal:  EMBO J       Date:  2012-10-02       Impact factor: 11.598

7.  Transgenic mice expressing constitutively active Akt in oral epithelium validate KLFA as a potential biomarker of head and neck squamous cell carcinoma.

Authors:  Marta Moral; Carmen Segrelles; Ana Belén Martínez-Cruz; Corina Lorz; Mirentxu Santos; Ramón García-Escudero; Jerry Lu; Agueda Buitrago; Clotilde Costa; Cristina Saiz; José M Ariza; Marta Dueñas; Jose L Rodriguez-Peralto; Francisco J Martinez-Tello; Maria Rodriguez-Pinilla; Montserrat Sanchez-Cespedes; John Digiovanni; Jesús M Paramio
Journal:  In Vivo       Date:  2009 Sep-Oct       Impact factor: 2.155

8.  Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers.

Authors:  Curtis R Pickering; Jiexin Zhang; Suk Young Yoo; Linnea Bengtsson; Shhyam Moorthy; David M Neskey; Mei Zhao; Marcus V Ortega Alves; Kyle Chang; Jennifer Drummond; Elsa Cortez; Tong-Xin Xie; Di Zhang; Woonbok Chung; Jean-Pierre J Issa; Patrick A Zweidler-McKay; Xifeng Wu; Adel K El-Naggar; John N Weinstein; Jing Wang; Donna M Muzny; Richard A Gibbs; David A Wheeler; Jeffrey N Myers; Mitchell J Frederick
Journal:  Cancer Discov       Date:  2013-04-25       Impact factor: 39.397

Review 9.  Contemporary management of cancer of the oral cavity.

Authors:  Eric M Genden; Alfio Ferlito; Carl E Silver; Robert P Takes; Carlos Suárez; Randall P Owen; Missak Haigentz; Sandro J Stoeckli; Ashok R Shaha; Alexander D Rapidis; Juan Pablo Rodrigo; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02-13       Impact factor: 2.503

10.  LCK, survivin and PI-3K in the molecular biomarker profiling of oral lichen planus and oral squamous cell carcinoma.

Authors:  Oluwadayo Oluwadara; Luca Giacomelli; Russell Christensen; George Kossan; Raisa Avezova; Francesco Chiappelli
Journal:  Bioinformation       Date:  2009-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.